Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.
Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...
A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...
Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
2d
GlobalData on MSNGLP-1RAs and opioid use disorder: a new frontier in addiction treatmentGlucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
US sweet protein startup Oobli has raised $18M and partnered with global ingredients giant Ingredion to develop ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results